Millipore Sigma Vibrant Logo
Atención: Nos hemos mudado. Los productos Merck Millipore ya no pueden adquirirse en MerckMillipore.comMás información

ASK10 MMP/TIMP Family Antibody Sampler Kit I

This MMP/TIMP Family Antibody Sampler Kit I is validated for use in Frozen Sections, Immunoblotting, IP, Paraffin Sections for the detection of MMP/TIMP Family Antibody Sampler Kit I.

MMP/TIMP Family Antibody Sampler Kit I: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.
ASK10
Purchase on Sigma-Aldrich

Descripción

Replacement Information

Products

Número de referenciaEmbalaje Cant./Env.
ASK10-1EA Ampolla de plást. 1 ea
Description
OverviewContains 20 µg of each antibody. Includes Anti-MMP-1 (Cat. No. IM35), Anti-MMP-2 (Cat. No. IM33), Anti-MMP-3 (Cat. No. IM36), Anti-MMP-9 (Cat. Nos. IM09 and IM37), Anti-TIMP-1 (Cat. No. IM32), and Anti-TIMP-2 (Cat. No. IM11). Please see individual product descriptions for more information.
Catalogue NumberASK10
Brand Family Calbiochem®
Application Data
References
ReferencesHöyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
Cottam, D. W. and Rees, R. C. 1993. Intl J. Oncol. 2, 861.
Fujimoto, N., et al. 1993. Clinica Chimica Acta. 221, 91.
Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
Stetler-Stevenson, W. G., et al. 1993. FASEB J. 7, 1434.
Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1.
Zucker, S., et al. 1993. Cancer Res. 53, 140.
Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59.
Woessner, J. F. 1991. FASEB J. 5, 2145.
Liotta, L. A. and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol.1(2); 99-102.
Kodama, S., et al. 1987. Collagen Rel. Res. 7, 341.
Product Information
DeclarationManufactured by Daiichi Fine Chemical Co., Ltd. Not available for sale in Japan.
FormLiquid
Formulation20 µg of each antibody in 100 mM sodium phosphate buffer, 0.1% BSA, pH 7.4.
Preservative≤0.1% sodium azide
Quality LevelMQ100
Applications
Application ReferencesMMP-9 (Ab-2) Frozen and Paraffin Sections Aikawa, M, et al. 1998. Circ. Res. 83, 1015. MMP-2 (Ab-3) Paraffin Sections: Tsuchiya, Y., et al. 1994. Int. J. Cancer. 56, 46. MMP-1 (Ab-1), MMP-2 (Ab-3), and MMP-3 (Ab-1) Frozen Sections Nakagawa, T., et al. 1994. J. Neurosurg. 81, 69. MMP-1 (Ab-1) Paraffin Sections: Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1. MMP-2 (Ab-3) Paraffin Sections Nomura H., et al. 1996. Int. J. Cancer 69, 9. Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59. (called clone B) MMP-9 (Ab-1) Enzyme Inhibition: Ramos-DeSimone, N., et al. 1993. Hybridoma 12, 349. MMP-9 (Ab-1) and MMP-9 (Ab-2) Immunoprecipitation Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci. 732, 469. TIMP-1 (Ab-1) Imunohistochemistry Okada, Y., et al. 1990. Virchows Arch. B Cell Pathol. 59, 305. TIMP-2 (Ab-1) Immunoprecipitation and Frozen Sections Höyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
Application NotesFrozen Sections (see characteristics below)
Immunoblotting (see characteristics below)
Immunoprecipitation (see characteristics below)
Paraffin Sections (see characteristics below)
Application CommentsFor an MMP-1 or MMP-3 positive control, incubate HT-1080 cells for 2 hours at 37°C in serum-free media containing 100 nM PMA. Collect and centrifuge medium; concentrate as necessary. Store in aliquots at -20°C. When staining paraffin sections for MMP-1, pretreatment with heat, saponin, or trypsin can be used, but a pressure cooker generally gives the best results. Anti-MMP-9 (Ab-1) recognizes both the latent and active forms of MMP-9 under non-reducing conditions but only the latent form under reducing conditions. Anti-MMP-9 (Ab-1) will inhibit MMP-9 enzymatic activity. Anti-MMP-9 (Ab-2) recognizes only the latent form of MMP-9 (non-reducing or reducing conditions). Anti-TIMP-1 (Ab-1) will react with TIMP-1 and MMP/TIMP-1 complexes. Antibodies should be titrated for optimal results in individual systems.
Biological Information
Concentration Label Please refer to vial label for lot-specific concentration
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage -20°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Número de referencia GTIN
ASK10-1EA 04055977212761

Documentation

MMP/TIMP Family Antibody Sampler Kit I Certificados de análisis

CargoNúmero de lote
ASK10

Referencias bibliográficas

Visión general referencias
Höyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
Cottam, D. W. and Rees, R. C. 1993. Intl J. Oncol. 2, 861.
Fujimoto, N., et al. 1993. Clinica Chimica Acta. 221, 91.
Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
Stetler-Stevenson, W. G., et al. 1993. FASEB J. 7, 1434.
Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1.
Zucker, S., et al. 1993. Cancer Res. 53, 140.
Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59.
Woessner, J. F. 1991. FASEB J. 5, 2145.
Liotta, L. A. and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol.1(2); 99-102.
Kodama, S., et al. 1987. Collagen Rel. Res. 7, 341.
Ficha técnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision03-December-2007 JSW
ApplicationFrozen Sections (see characteristics below)
Immunoblotting (see characteristics below)
Immunoprecipitation (see characteristics below)
Paraffin Sections (see characteristics below)
Application Data
DescriptionContains 20 µg of each antibody. Includes Anti-MMP-1 (Cat. No. IM35), Anti-MMP-2 (Cat. No. IM33), Anti-MMP-3 (Cat. No. IM36), Anti-MMP-9 (Cat. Nos. IM09 and IM37), Anti-TIMP-1 (Cat. No. IM32), and Anti-TIMP-2 (Cat. No. IM11). Please see individual product descriptions for more information. The antibodies to MMP-1, MMP-2, and MMP-3 recognize both latent and active forms.
BackgroundMatrix metalloproteinases (MMPs) are a family of enzymes that are responsible for the degradation of extracellular matrix components such as collagen, laminin and proteoglycans. All MMPs share: sequence homology, a catalytic mechanism dependent upon a zinc ion at the active center, ability to cleave one or more extracellular matrix components, secretion as zymogens which are activated by removal of an approximately 10 kDa segment from the N-terminus, and regulation by endogenous inhibitors. These enzymes are involved in normal physiological processes as well as in metastasis. MMP-2 and MMP-9 are members of the gelatinase family and elevated levels may be correlated with metastatic potential. MMP-1 is also known as interstitial collagenase and MMP-3 as stromelysin-1. Activation and activity of the MMP's are regulated by the TIMP (tissue inhibitors of metalloproteinase) family members. TIMP-1 preferentially regulates MMP-9 and TIMP-2 regulates MMP-2.
FormLiquid
Formulation20 µg of each antibody in 100 mM sodium phosphate buffer, 0.1% BSA, pH 7.4.
Concentration Label Please refer to vial label for lot-specific concentration
Preservative≤0.1% sodium azide
CommentsFor an MMP-1 or MMP-3 positive control, incubate HT-1080 cells for 2 hours at 37°C in serum-free media containing 100 nM PMA. Collect and centrifuge medium; concentrate as necessary. Store in aliquots at -20°C. When staining paraffin sections for MMP-1, pretreatment with heat, saponin, or trypsin can be used, but a pressure cooker generally gives the best results. Anti-MMP-9 (Ab-1) recognizes both the latent and active forms of MMP-9 under non-reducing conditions but only the latent form under reducing conditions. Anti-MMP-9 (Ab-1) will inhibit MMP-9 enzymatic activity. Anti-MMP-9 (Ab-2) recognizes only the latent form of MMP-9 (non-reducing or reducing conditions). Anti-TIMP-1 (Ab-1) will react with TIMP-1 and MMP/TIMP-1 complexes. Antibodies should be titrated for optimal results in individual systems.
Storage Avoid freeze/thaw
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
Toxicity Standard Handling
ReferencesHöyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.
Cottam, D. W. and Rees, R. C. 1993. Intl J. Oncol. 2, 861.
Fujimoto, N., et al. 1993. Clinica Chimica Acta. 221, 91.
Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
Stetler-Stevenson, W. G., et al. 1993. FASEB J. 7, 1434.
Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1.
Zucker, S., et al. 1993. Cancer Res. 53, 140.
Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59.
Woessner, J. F. 1991. FASEB J. 5, 2145.
Liotta, L. A. and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol.1(2); 99-102.
Kodama, S., et al. 1987. Collagen Rel. Res. 7, 341.
Application referencesMMP-9 (Ab-2) Frozen and Paraffin Sections Aikawa, M, et al. 1998. Circ. Res. 83, 1015. MMP-2 (Ab-3) Paraffin Sections: Tsuchiya, Y., et al. 1994. Int. J. Cancer. 56, 46. MMP-1 (Ab-1), MMP-2 (Ab-3), and MMP-3 (Ab-1) Frozen Sections Nakagawa, T., et al. 1994. J. Neurosurg. 81, 69. MMP-1 (Ab-1) Paraffin Sections: Zhang, J., et al. 1993. Clinica Chimica Acta. 219, 1. MMP-2 (Ab-3) Paraffin Sections Nomura H., et al. 1996. Int. J. Cancer 69, 9. Obata, K., et al. 1992. Clinica Chimica Acta. 211, 59. (called clone B) MMP-9 (Ab-1) Enzyme Inhibition: Ramos-DeSimone, N., et al. 1993. Hybridoma 12, 349. MMP-9 (Ab-1) and MMP-9 (Ab-2) Immunoprecipitation Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci. 732, 469. TIMP-1 (Ab-1) Imunohistochemistry Okada, Y., et al. 1990. Virchows Arch. B Cell Pathol. 59, 305. TIMP-2 (Ab-1) Immunoprecipitation and Frozen Sections Höyhtyä, M., et al. 1994. Int. J. Cancer. 56, 500.